Workflow
Allogeneic cell therapy platform
icon
Search documents
Allogene Therapeutics: Important Catalysts Guided For Early 2026
Seeking Alphaยท 2025-08-14 19:02
I've remained tentatively optimistic about the prospects of Allogene Therapeutics (NASDAQ: ALLO ) and their allogeneic cell therapy platform, with most of my concerns being the long lead time to a potential drugI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of in ...